Lokalpressen Partille nr 21 26 sept 2018 by Lokalpressen - Issuu
PDF) A rapid, highly accurate method for quantifying CALR mutant allele burden in persons with myeloproliferative neoplasms
Therapeutic Potential of an Antibody Targeting the Cleaved Form of Mutant Calreticulin in Myeloproliferative Neoplasms - ScienceDirect
Discovery of a new anti-CALR mutant monoclonal antibody for the treatment of MPN
Var beredd på cykeltjuven
Rare type 1-like and type 2-like calreticulin mutants induce similar myeloproliferative neoplasms as prevalent type 1 and 2 mutants in mice | Oncogene
Differential Dynamics of CALR Mutant Allele Burden in Myeloproliferative Neoplasms during Interferon Alfa Treatment | PLOS ONE
Mayo CALR mutation type classification guide using alpha helix propensity - Lasho - 2018 - American Journal of Hematology - Wiley Online Library
Rare type 1-like and type 2-like calreticulin mutants induce similar myeloproliferative neoplasms as prevalent type 1 and 2 mutants in mice | Oncogene
CALR Mutations Type 1 and Type 2 in Unmutant JAK2 Myeloproliferative Neoplasms in Sudanese Patients
sou 1999 117 - Regeringen
Rare type 1-like and type 2-like calreticulin mutants induce similar myeloproliferative neoplasms as prevalent type 1 and 2 mutants in mice | Oncogene
Differential Dynamics of CALR Mutant Allele Burden in Myeloproliferative Neoplasms during Interferon Alfa Treatment | PLOS ONE
Discovery of a new anti-CALR mutant monoclonal antibody for the treatment of MPN
CALR Mutations Type 1 and Type 2 in Unmutant JAK2 Myeloproliferative Neoplasms in Sudanese Patients
Rare type 1-like and type 2-like calreticulin mutants induce similar myeloproliferative neoplasms as prevalent type 1 and 2 mutants in mice | Oncogene
PDF) A rapid, highly accurate method for quantifying CALR mutant allele burden in persons with myeloproliferative neoplasms
CALR Mutations Type 1 and Type 2 in Unmutant JAK2 Myeloproliferative Neoplasms in Sudanese Patients
PDF) A rapid, highly accurate method for quantifying CALR mutant allele burden in persons with myeloproliferative neoplasms
Mayo CALR mutation type classification guide using alpha helix propensity - Lasho - 2018 - American Journal of Hematology - Wiley Online Library
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms | Leukemia
Myeloproliferative Neoplasms: Targeting CALR With Novel Therapy
Med nål och tråd
